Campylobacter jejuni is unable to utilize glucose as a carbon source due to the absence of the key glycolytic enzyme 6-phosphofructokinase. The genome sequence of C. jejuni NCTC 11168 indicates that homologues of all the appropriate enzymes for gluconeogenesis from phosphoenolpyruvate (PEP) are present, in addition to the anaplerotic enzymes pyruvate carboxylase (PYC), phosphoenolpyruvate carboxykinase (PCK) and malic enzyme (MEZ). Surprisingly, a pyruvate kinase (PYK) homologue is also present. To ascertain the role of these enzymes, insertion mutants in pycA, pycB, pyk and mez were generated. However, this could not be acheived for pckA, indicating that PCK is an essential enzyme in C. jejuni. The lack of PEP synthase and pyruvate orthophosphate dikinase activities confirmed a unique role for PCK in PEP synthesis. The pycA mutant was unable to grow in defined medium with pyruvate or lactate as the major carbon source, thus indicating an important role for PYC in anaplerosis. Sequence and biochemical data indicate that the PYC of C. jejuni is a member of the α 4 β 4 , acetyl-CoA-independent class of PYCs, with a 658 kDa subunit containing the biotin moiety. Whereas growth of the mez mutant was comparable to that of the wild-type, the pyk mutant displayed a decreased growth rate in complex medium. Nevertheless, the mez and pyk mutants were able to grow with pyruvate, lactate or malate as carbon sources in defined medium. PYK was present in cell extracts at a much higher specific activity [S 800 nmol min N1 (mg protein) N1 ] than PYC or PCK [T 65 nmol min N1 (mg protein) N1 ], was activated by fructose 1,6-bisphosphate and displayed other regulatory properties strongly indicative of a catabolic role. It is concluded that PYK may function in the catabolism of unidentified substrates which are metabolized through PEP. In view of the high K m of MEZ for malate (" " " 9 mM) and the lack of a growth phenotype of the mez mutant, MEZ seems to have only a minor anaplerotic role in C. jejuni.
INTRODUCTION
Campylobacter jejuni is a Gram-negative, microaerophilic bacterium recognized as a primary cause of enteric disease worldwide (Tauxe, 1992) . Human infection is usually acquired by the consumption of contaminated 
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food, particularly poultry, milk and water. Several factors that contribute to the pathogenesis of C. jejuni have been identified, including motility, adhesion, the ability to invade host cells and the production of several toxins (Ketley, 1997) . Although the organism can clearly adapt its metabolism to a range of different environments, within and outside of the host, the factors that contribute to its metabolic versatility are poorly defined.
The complete genome sequence of C. jejuni NCTC 11168 (Parkhill et al., 2000) has provided numerous insights into the metabolism and physiology of this 
Fig. 1.
Outline of the gluconeogenic and anaplerotic reactions of C. jejuni, based on genome sequence data and biochemical data. The broken arrow highlights the CAC-replenishing anaplerotic reaction of PYC. Numbers indicate genes for the following enzymes : 1, glucose-6-phosphate isomerase ; 2, 6-phosphofructokinase, the asterisk indicates that the C. jejuni genome lacks a homologue for the 6-phosphofructokinase, which catalyses the irreversible phosphorylation of fructose 6-phosphate to F1,6-BP in glycolysis ; 3, fructose-1,6-bisphosphatase ; 4, fructose-bisphosphate aldolase ; 5, triosephosphate isomerase ; 6, glyceraldehyde-3-phosphate dehydrogenase ; 7, phosphoglycerate kinase ; 8, phosphoglycerate mutase ; 9, enolase ; 10, PYK ; 11, PYC ; 12, PCK ; 13, MEZ ; 14, malate dehydrogenase ; 15, malate : quinone oxidoreductase, possibly encoded by Cj0393c. organism. Although it is widely accepted that C. jejuni neither oxidizes nor ferments glucose (Smibert, 1984) , genes encoding enzymes of the Embden-Meyerhof and pentose phosphate pathways are present in the genome (Parkhill et al., 2000) . Most of the reactions of the Embden-Meyerhof pathway are reversible in vivo, with the notable exceptions of the 6-phosphofructokinase and pyruvate kinase (PYK) reactions (Fig. 1) , both of which constitute key control points. C. jejuni lacks a gene that could encode a 6-phosphofructokinase, which may account for the inability of the bacterium to catabolize glucose. However, a gene encoding fructose-1,6-bisphosphatase is present (Fig. 1) , which strongly suggests that the Embden-Meyerhof pathway functions in gluconeogenesis. Nevertheless, a homologue of PYK (Cj0392c) has also been identified (Parkhill et al., 2000) . This is surprising, since PYK catalyses the physiologically irreversible conversion of phosphoenolpyruvate (PEP) and ADP to pyruvate and ATP at the final stage of the glycolytic pathway (Fig. 1) .
C. jejuni is predicted to possess a complete citric acid cycle (CAC) (Parkhill et al., 2000 ; Kelly, 2001) . The net synthesis of oxaloacetate (OAA) from pyruvate or PEP is required to permit the CAC to fulfil both its biosynthetic and its energy-generating roles. C. jejuni possesses homologues of anaplerotic enzymes that may function in this capacity. These are as follows. (i) Pyruvate carboxylase (PYC) encoded by pycA (Cj1037c) and pycB (Cj0933c) homologues, which correspond to the biotin carboxylase and biotin carboxyl carrier subunits, respectively, of the two-subunit type of carboxylase (Goss et al., 1981) . PYC is a biotin-containing enzyme that fulfils an important anaplerotic function in many organisms by catalysing the ATP-dependent carboxylation of pyruvate to yield OAA (Fig. 1). (ii) Phosphoenolpyruvate carboxykinase (PCK) which provides the PEP required for gluconeogenesis (Fig. 1) . PCK catalyses the ATP-dependent decarboxylation of OAA to PEP. C. jejuni has a homologue of the Escherichia coli pckA gene (Cj0932c) and, interestingly, it is contiguous with the pycB homologue. (iii) Besides PYC and PCK, the only other predicted decarboxylating\ carboxylating enzyme located at the metabolic node around pyruvate is malate oxidoreductase [malic enzyme (MEZ)]. MEZ catalyses the oxidative decarboxylation of malate to pyruvate coupled with NAD(P) reduction (Fig. 1 ). Cj1287c encodes a probable malate oxidoreductase, homologous to that of Bacillus stearothermophilus (Parkhill et al., 2000) .
Given the likely gluconeogenic role of the EmbdenMeyerhof pathway in C. jejuni, the presence and role of PYK is particularly enigmatic, as a futile cycle could result from the PYC, PCK and PYK reactions (Fig. 1) . This study was undertaken to investigate the physiological function of the anaplerotic enzymes in C. jejuni and to determine the mode of regulation of the PYK. The phenotypic consequences of the mutational inactivation of PYK and the anaplerotic enzymes in C. jejuni are reported, permitting the assignment of definitive functions to several genes identified in the complete genome sequence (Parkhill et al., 2000) .
METHODS
Bacterial strains, media and culture conditions. C. jejuni strains were routinely grown at 37 mC under microaerobic conditions [10 % (v\v) O # , 5% (v\v) CO # and 85 % (v\v) N # ] in a MACS-VA500 cabinet (Don Whitley Scientific) on Columbia agar containing 5 % (v\v) lysed horse blood and 10 µg ml − " each of amphotericin B and vancomycin. Liquid cultures of C. jejuni were grown with gentle agitation under the same conditions, in brain heart infusion (BHI) broth supplemented with 5 % (v\v) fetal calf serum or in the defined medium MEMα (Gibco), both containing the above antibiotics. MEMα is composed of a mixture of inorganic salts, amino acids, vitamins, ribonucleosides and deoxyribonucleosides. To select for C. jejuni mutants carrying antibioticresistant determinants, either kanamycin or chloramphenicol For growth assays, C. jejuni overnight starter cultures were prepared in BHI broth before inoculation into fresh BHI or MEMα medium to which selected carbon sources at specified concentrations were added. Growth was monitored at 600 nm in an Amersham Pharmacia Biotech Ultrospec 2000 spectrophotometer.
DNA isolation and manipulation. Plasmid DNA was isolated using the Qiagen Miniprep kit. C. jejuni chromosomal DNA was extracted using a modified SDS lysis procedure (Marmur, 1961) . Standard techniques were employed for the cloning, transformation, preparation and restriction analysis of plasmid DNA from E. coli (Sambrook et al., 1989) .
Preparation of cell extracts and enzyme assays. Cell-free extracts were prepared from 300 ml cultures grown to stationary phase. Cells were harvested in a Beckman Avanti J-25 I centrifuge (20 min, 4 mC, 8000 g), washed with 0n1 M Tris\HCl (pH 8n0) and then resuspended in 1 ml of the same buffer before sonication (MSE Soniprep 150, 6i10 s bursts, 12 µm amplitude). The crude extract was clarified by centrifugation (30 min, 14 000 g) and the supernatant was retained for use on the same day.
PYC and PCK activities were monitored in assays linked to the NADH-dependent reduction of OAA by malate dehydrogenase. Each 1 ml PYC assay mixture contained 0n1 M Tris\HCl (pH 8n0), 5 mM sodium pyruvate, 5 mM ATP, 50 mM NaHCO $ , 5 mM MgCl # , 0n25 mM NADH, 2 U malate dehydrogenase (Sigma) and cell extract. The reaction was initiated by the addition of pyruvate, and the disappearance of NADH was monitored continuously at 340 nm. PCK activity was measured in 1 ml assays containing 100 mM MOPS (pH 7n0), 50 mM NaHCO $ , 4 mM ADP, 2n5 mM MgCl # , 2 mM MnCl # , 0n25 mM NADH, 2 mM PEP, 2 U malate dehydrogenase and cell extract. MEZ activity was assayed in a 1 ml mixture containing 0n1 M Tris\HCl (pH 7n0), 2 mM MnCl # , 5 mM KCl, 2n5 mM NADP, 7n5 mM -malate and cell extract. PYK activity was assayed in a mixture containing 0n1 M Tris\HCl (pH 7n0), 30 mM MgSO % , 10 mM ADP, 0n25 mM NADH, 5 mM PEP, 5 U lactate dehydrogenase (Sigma) and cell extract. The K m , V max and Hill coefficients of the enzymes were estimated by using the curve-fitting package Enzfitter from Biosoft.
Detection of biotinylated proteins. Cell extracts from wildtype and pyc mutant cells, grown in BHI broth, were prepared as described above. Denatured extracted protein (0n3 mg) was loaded and separated by SDS-PAGE (12 %, w\v, acrylamide), then electroblotted onto a PVDF membrane (Millipore) in a Bio-Rad Transblot cell at 250 mA for 16 h. Biotinylated polypeptides were detected using an avidin-horseradish peroxidase conjugate (Bio-Rad), according to the instructions of the manufacturer.
Insertional inactivation of the pycA, pycB, pyk, pckA and mez genes. Primers PYCA-F and PYCA-R (Table 1) were designed to amplify a 1n4 kb fragment of the pycA homologue (Cj1037c) by PCR. This fragment was subsequently cloned into pGEM-T Easy (Promega). The aphA-3-containing SmaI fragment of pJMK30 (van Vliet et al., 1998) , which confers kanamycin resistance, was then cloned into the BglII site within the Cj1037c gene to generate pJV1. The C. jejuni pycB homologue (Cj0933c) was amplified with the primers PYCB-F and PYCB-R (Table 1) and cloned into pGEM-T Easy. A chloramphenicol-acetyltransferase (CAT) cassette, originating from Campylobacter coli (Wang & Taylor, 1990) , was then cloned into a unique BstXI site located within the cloned pycB gene to generate pJV2. For the inactivation of the pckA homologue (Cj0932c), primers PCKA-F and PCKA-R (Table  1) were used to amplify a 1n4 kb fragment of Cj0932c from chromosomal DNA and the resulting amplicon was cloned into pGEM-T Easy. The CAT cassette was then cloned into a unique BstEII site within the cloned Cj0932c fragment, yielding pJV3. A fragment of the pyk homologue (Cj0392c) was amplified with PYK-F and PYK-R (Table 1 ). The resulting amplicon was cloned into pGEM-T Easy and the CAT cassette was inserted into the unique KpnI site within the cloned pyk gene ; this construct was named pJV4.
For the inactivation of the putative MEZ gene (here designated mez) primers MEZ-F and MEZ-R (Table 1) were used to amplify a fragment of Cj1287c. The 1n4 kb fragment was cloned into pGEM-T Easy and the aphA-3 gene was then ligated to the unique BsmI site within the cloned fragment, producing pJV5. Except where indicated, all constructs contained the antibiotic-resistance cartridge in the same transcriptional orientation as that of the gene ( Fig. 2a-d ).
All antibiotic-resistant constructs were introduced into C. jejuni NCTC 11168 by electroporation (Ferrero et al., 1992) . Transformants were selected on Columbia agar plates supplemented with the appropriate antibiotic. Single colonies were restreaked and chromosomal DNA was extracted by the microLYSIS kit (Web Scientific) for screening by PCR, to ensure that allelic exchange had occurred by double-homologous recombination. ) and mez (lane 9) mutants, using primers PYCA-F and PYCA-R (lanes 2 and 3), PYCB-F and PYCB-R (lanes 4 and 5), PYK-F and PYK-R (lanes 6 and 7) or MEZ-F and MEZ-R (lanes 8 and 9). Lane 1 contains a 1 kb DNA ladder. The size increase of the PCR products obtained when mutant DNA was used as the template corresponds to the 0n75 and 1n5 kb cat and aphA-3 cassettes, respectively.
RESULTS
Inactivation of the chromosomal pycA, pycB, pyk, pckA and mez genes As a first step towards defining roles for PYC, PYK, PCK and MEZ, mutants were constructed by the insertion of non-polar antibiotic-resistance cassettes (containing an internal promoter, but no transcriptional terminators) into unique restriction sites within the cloned genes to give pJV1-pJV5 (Fig. 2) . These constructs were electroporated into C. jejuni NCTC 11168, generating chromosomal null mutants of pycA, pycB, pyk and the mez gene by homologous recombination. The correct construction of the mutants was confirmed by PCR amplification of the target genes, which yielded fragment sizes consistent with the insertion of the 0n75 and 1n5 kb chloramphenicol-and kanamycin-resistance cassettes, respectively (Fig. 2) . Despite numerous attempts, no chloramphenicol-resistant colonies were obtained with pJV3. As other transformations performed in parallel were successful, this indicates that pckA is an essential gene. All of the genes that were successfully inactivated contained the antibiotic-resistance determinant in the same transcriptional orientation as that of the target gene, with the exception of pycB. Mutants of pycB could only be obtained with constructs containing the antibiotic-resistance cassette in the opposite transcriptional orientation to that of the gene. It is likely that this requirement for a specific orientation is due to polar effects on the level of expression of the downstream pckA (see below). Insertion of the antibiotic-resistance cassette in the same direction as that of the pycB gene may result in a level of PCK which is superoptimal and, therefore, detrimental to growth. Conversely, as shown in the following section, the presence of the antibioticresistance cassette in the opposite orientation in pycB 
still resulted in weak PCK activity, sufficient to support growth of the pycB mutant.
Enzymic properties of the pycA, pycB, pyk and mez mutants
The wild-type strain and the mutants were assayed for their PYC, PYK, PCK and MEZ activities, to investigate whether mutations in the pyk, pycA, pycB and mez genes affected enzyme activity at the metabolic junction around pyruvate. The results are displayed in Table 2 . PYC activity was completely abolished in the pycA and pycB mutants. PYK activity was reduced somewhat in the pyc mutants, with this effect being more pronounced with the pycB mutant (approximately twofold lower than that of the wild-type). Whereas PCK activity was not altered in the pycA mutant, the pycB mutant displayed an approximately ninefold reduction in PCK activity. This indicates that the pycB mutation is polar, affecting the expression of pckA (which lies 13 bp downstream of the pycB gene). MEZ activity was reduced fourfold in the pycA mutant, although MEZ activity in the pycB mutant was similar to that of the wild-type. The reason for this discrepancy is unclear. As shown in Table 2 , the pyk mutant was devoid of PYK activity. Although MEZ and PYC activities in the pyk mutant were comparable to those in the wild-type, PCK activity was reduced by approximately threefold. It should be noted that although PEP and ADP are substrates for the PYK reaction they are also substrates for PCK in PEP carboxylation (Fig. 1) , but the latter reaction also requires bicarbonate. Hence, the PYK assay is specific and this is confirmed by the lack of any residual activity in the pyk mutant. The possibility that PYK activity interferes with the PCK assay is precluded by the fact that the pyk mutant displays decreased (not increased) PCK activity. MEZ activity was abolished in the mez mutant (Table 2) , thus confirming the identity of Cj1287c as the gene that encodes MEZ. PYC, PYK and PCK activities remained largely unaltered in this strain. Extracts of the wild-type strain were devoid of pyruvate orthophosphate dikinase activity, which catalyses the reversible, ATP-dependent conversion of pyruvate to PEP. Furthermore, no PEP synthase activity was detected in wild-type cell extracts. PEP synthase catalyses the conversion of pyruvate and ATP to PEP, AMP and phosphate, and is thought to function in gluconeogenesis. Thus, PCK appears to be the only means of synthesizing PEP, which is consistent with the failure to isolate a pckA mutant.
Growth characteristics of the pycA, pycB, pyk and mez mutants
The effect of mutations in PYK and in the anaplerotic enzymes on the growth of C. jejuni NCTC 11168 was determined in BHI broth (Fig. 3) . Doubling times for the wild-type strain and the pycA mutant were almost identical (" 2 and " 3 h, respectively), with their final growth yields being similar (Fig. 3a) . The pycB mutant, however, displayed a significant reduction in both growth rate and yield, with a doubling time of " 7 h and an approximately threefold reduction in the final extent of growth (Fig. 3a) . Moreover, supplementation of the growth medium with malate did not rescue the growth defect of the pycB mutant (data not shown). The pyk mutant exhibited a decreased growth rate compared to that of the wild-type, with a doubling time of " 5 h, although the final extent of growth was not affected (Fig.  3b) . The addition of pyruvate to the medium did not enhance the growth rate of the pyk mutant (data not shown). Growth of the mez mutant, with respect to both the growth rate and the final cell yields, was comparable to that of the wild-type (Fig. 3c) . To determine the carbon sources capable of supporting the growth of the wild-type and the mutant strains, growth assays were repeated using the defined medium MEMα. Growth of the pycA mutant and the parent strains in MEMα supplemented with either pyruvate, lactate or malate showed that the mutant was severely impaired in its growth when pyruvate or lactate was the major carbon source, although its growth on malate was not affected (Fig. 4a) . The pycB mutant, on the other hand, was unable to grow on lactate, pyruvate or malate (Fig. 4a) . These results indicate that the PYC in C. jejuni contributes significantly to growth on lactate and on pyruvate. To test the hypothesis that a depletion in intracellular OAA is responsible for the deficient growth of the pycA mutant on pyruvate and on lactate, a small amount (1 mM) of malate was added to a pycA mutant culture, with lactate (20 mM) as the major carbon source. The addition of malate restored the final cell density of the pycA mutant to the wild-type level (Fig.  4b ). The addition of the same concentration of malate to the wild-type had no effect on its growth (Fig. 4b) . The 
Fig. 5.
Detection of biotinylated polypeptides in wild-type cell extracts and in pycA and pycB mutant cell extracts. The denatured proteins were separated in a 12 % polyacrylamide gel. The amount of cell extract protein per lane was 0n3 mg. The biotin-containing polypeptide bands were detected using an avidin-horseradish peroxidase conjugate. Lanes : 1 and 5, biotinylated molecular mass markers, phosphorylase B, 97n4 kDa, bovine serum albumin, 66n2 kDa, ovalbumin, 45n0 kDa, carbonic anhydrase, 31n0 kDa, soybean trypsin inhibitor, 21n5 kDa, lysosyme, 14n4 kDa ; 2, pycB mutant ; 3, pycA mutant ; 4, C. jejuni wild-type.
inability of the pycB mutant to utilize malate as a carbon source is almost certainly a result of the marked reduction in PCK activity, thus indicating the importance of PCK during growth on malate. Growth of the pyk and the mez mutants on all three carbon sources was comparable to that of the wild-type (Fig. 4a) .
Synthesis of the biotinylated PYCB protein in the pycA mutant
Several carboxylases, most notably pyruvate carboxylase and acetyl-CoA carboxylase, possess covalently bound biotin at their active sites. Western blots of C. jejuni NCTC 11168 cytosolic proteins probed with avidin-horseradish peroxidase revealed at least two biotinylated polypeptides of approximately 65 and 23 kDa (Fig. 5) , the former being the most abundant. This is likely to be the PYCB protein, the predicted molecular mass of which is 65n8 kDa. The pycB mutant was specifically deficient in the 65 kDa protein, thus establishing its identity as the biotinylated subunit of PYC. The pycA mutant, on the other hand, shared the same biotinylated-protein profile with the wild-type, suggesting that although PYCB is still synthesized, the lack of PYCA prevents the assembly of a functional protein. The 23 kDa protein is similar in size to the biotin carboxyl carrier proteins of acetyl-CoA carboxylases from E. coli, Anabaena sp. strain PCC 7120 and Pseudomonas aeruginosa (Li & Cronan, 1992 ; Gornicki et al., 1993 ; Best & Knauf, 1993) .
Biochemical characteristics of anaplerotic enzymes in wild-type cells
The activity of PYC was strictly dependent on the presence of ATP, pyruvate, bicarbonate and Mg# + , although the requirement for the presence of a divalent cation could be fulfilled by Co# + and poorly by Mn# + . PEP could not substitute for pyruvate and ATP could not be replaced with ADP or AMP. In the presence of ATP, both AMP and ADP acted as potent inhibitors (Fig. 6a) . Similar to other PYCs, ATP inhibited the enzyme when present at concentrations above 7 mM. The inhibition caused by ATP was relieved by the presence of excess Mg# + . Incubation of the cell extract with avidin completely abolished PYC activity (Fig. 6a) . PYC activity was not affected by acetyl-CoA (Fig. 6a) . Although insensitive to 2-oxoglutarate, PYC was significantly inhibited by glutamate and aspartate (Fig. 6a) .
Michaelis-Menten kinetics were followed when the initial velocity was plotted against varying pyruvate and bicarbonate concentrations (Table 3) . The PYK of C. jejuni exhibited classical saturation kinetics with ADP, whereas the enzyme was sigmoidally dependent on the PEP concentration, indicating moderate positive co-operativity (Table 3) , as is often found in allosteric enzymes. Although maximal PYK activity was detected in the presence of Mg# + , Ni# + or Co# + could substitute to some extent. No activity was detected in the absence of a divalent cation. The catalytic activity of PYK is controlled in nearly all organisms by one or more allosteric effectors. PYKs of bacterial origin are normally homotropically activated by PEP and the allosteric effectors fructose 1,6-bisphosphate (F1,6-BP), AMP and\or sugar monophosphates. Furthermore, most PYKs exhibit co-operativity and allosteric inhibition by ATP (Mattevi et al., 1996) . As shown in Fig.  6(b) , F1,6-BP, glucose 6-phosphate (G6-P) and AMP activated PYK, whereas ATP was inhibitory and ribose 5-phosphate exerted little effect. PCK activity displayed an absolute dependence on the presence of divalent metal cations. Both Mg# + and Mn# + were required for maximal activity. When ATP and AMP were substituted for ADP, PCK activity was not detected. ATP and AMP strongly inhibited PCK activity in the presence of 4 mM ADP (Fig. 6c) . Moreover, 2-oxoglutarate and glutamate also inhibited PCK activity (Fig. 6c) . The bicarbonate concentration dependency of PCK activity deviated from Michaelis-Menten kinetics, being linear at concentrations of up to 140 mM. PCK observed hyperbolic kinetics when the initial velocity was plotted against PEP concentration (Table 3) . Effector studies and kinetics for PCK were also performed on the pyk mutant and gave similar data (not shown) to those obtained for the wild-type strain, ruling out the possibility of interference of the PCK activity by PYK.
The MEZ activity of C. jejuni NCTC 11168 was strictly dependent on NADP ; no activity was detected with NAD as a cofactor. Furthermore, no activity was measurable with -malate. MEZ displayed sigmoidal kinetics when -malate was the variable substrate. The affinity of the enzyme for malate was very low, with an apparent K m of 8n97 mM (Table 3 ). The Hill coefficient ( (Gourdon et al., 2000 ; Driscoll & Finan, 1996) . Similarly, the MEZ activity of C. jejuni was increased three-and twofold in the presence of K + and NH + % , respectively. In addition, MEZ activity was not affected by glutamate or AMP, whereas ATP, PEP and F1,6-BP markedly inhibited activity. G6-P, on the other hand, enhanced MEZ activity (Fig. 6d) .
DISCUSSION
In this study, we have examined the metabolic alterations that occur in C. jejuni as a consequence of the mutational inactivation of PYK and the anaplerotic enzymes PYC and MEZ. The diminished PYK activity observed in the pycA and pycB mutants is suggestive of negative control of PYK by pyruvate. Similarly, negative regulation of PCK activity by PEP is observed in the pyk mutant. The reduced growth of the pycA mutant on pyruvate and on lactate, but not on malate, as compared to the wild-type clearly indicates a role for PYC during growth on pyruvate and lactate. Restoration of the growth of the pycA mutant on pyruvate by the addition of a low concentration of malate is clearly indicative of an anaplerotic function. Bacterial and eukaryotic PYCs described to date are homotetramers (α % ) of 110-130 kDa, with the exception of the Pseudomonas citronellolis, Azotobacter vinelandii and Methanobacterium thermoautotrophicum PYCs, which have an α % β % structure. The α subunit (65 kDa), encoded by pycB, carries the biotin moiety and contains all of the catalytically active sites necessary for the PYC reaction. The β subunit (45 kDa), encoded by pycA, offers conformational stability within the enzyme's core (Goss et al., 1981 ; Mukhopadhyay et al., 1998) . In contrast to the α % PYCs, all of which require or are stimulated by acetyl-CoA, the α % β % enzymes are fully active in the absence of this effector (Cohen et al., 1979 ; Mukhopadhyay et al., 1998) . The presence of two genes that encode the 65 kDa and 54 kDa subunits of PYC, the lack of a 65 kDa biotinylated band in the pycB mutant and the inability of acetyl-CoA to activate the PYC of C. jejuni suggest that this enzyme is most likely to be of the α % β % type. The α % β % PYCs also appear to be insensitive to the other characteristic metabolic inhibitors described thus far for this enzyme, including -aspartate and glutamate which are potent inhibitors of some eukaryotic, bacterial and fungal PYCs (Mukhopadhyay & Purwantini, 2000 ; Modak & Kelly, 1995 ; Fier & Suzuki, 1969) . The presence of a PEP carboxylase, which is regulated by acetyl-CoA and -aspartate (Liao & Atkinson, 1971 ; O'Brien et al., 1977) , in organisms possessing α % β % PYCs is noteworthy. Moreover, PYC content in these organisms is a function of the carbon source used for growth (O'Brien et al., 1977 ; Scrutton & Taylor, 1974) . It seems reasonable to conclude, therefore, that ' fine ' control is not involved in the regulation of pyruvate carboxylation in these species. C. jejuni, on the other hand, has only a single enzyme (PYC) with the capacity to catalyse net synthesis of OAA from a three-carbon precursor, and therefore might be expected to display markedly different regulatory properties. In accord with this supposition, the C. jejuni enzyme was found to be potently inhibited by -aspartate and by glutamate, both of which could potentially be catabolized by aspartate aminotransferase to produce OAA, the product of the PYC reaction.
Almost all of the bacterial PYKs are activated by phosphorylated sugars and adenosine mono-or diphosphates, the latter of which are indicative of a low cellular energy charge. F1,6-BP, the product of the reaction catalysed by 6-phosphofructokinase, allosterically regulates PYK via feed-forward activation, whereas ATP, the product of the PYK reaction itself, regulates via feed-back inhibition. The PYK of C. jejuni NCTC 11168 is typical of a glycolytic enzyme with respect to its activation by F1,6-BP, G6-P and AMP, and its inhibition by ATP. Moreover, the higher specific activity of PYK compared to that of PYC, PCK and MEZ is notable. These findings are surprising in view of the fact that C. jejuni does not catabolize glucose, as reported by Smibert (1984) . Determination of glucose utilization using nuclear magnetic resonance assays of culture supernatants has confirmed the inability of C. jejuni to metabolize glucose (J. Velayudhan, S. Hall and D. J. Kelly, unpublished data) . This may be attributed to the absence of 6-phosphofructokinase, which is a key regulatory enzyme for sugar degradation via the Embden-Meyerhof pathway (Fig. 1) . The role of PYK in C. jejuni could be to metabolize an as yet unidentified substrate in a pathway that bypasses 6-phosphofructokinase, allowing for ATP synthesis by substratelevel phosphorylation. Substrates of the pentose phosphate pathway are one possibility. The presence of homologues for the non-oxidative branch of the pentose phosphate pathway in the C. jejuni genome could allow growth on pentoses. However, neither ribose, xylose nor arabinose was capable of supporting the growth of C. jejuni in MEMα (J. Velayudhan and D. J. Kelly, unpublished data). In congruence with the activation of the PYK of C. jejuni by F1,6-BP, primary sequence comparisons reveal that residue 403 of the PYK is a serine. In non-regulated PYKs this residue is strictly conserved as a glutamic acid, which may lead to ineffective binding of F1,6-BP (Jurica et al., 1998) . Furthermore, residues Thr378-Ser-Ser-Gly-Lys-Ser383 in the PYK of C. jejuni correspond to a well-defined phosphate-binding pocket in the yeast PYK, at which the 6h-phosphate of F1,6-BP makes a series of hydrogen bonds to the side chains of these residues.
The inability to construct a pckA mutant and the detrimental effect of reduced PCK activity on the growth of the polar pycB mutant indicates that PCK activity is indispensable for the growth of C. jejuni. The paucity of alternative enzymes that can function in the capacity of PEP synthesis, as indicated by enzyme assays, suggests that OAA decarboxylation by PCK is crucial for precursor synthesis for anabolic pathways that leave central metabolism upstream of PEP. The direction in which PCK operates is probably determined by the ratio of adenine nucleotide pools and the steady-state concentrations of OAA and PEP, hence the sensitivity of the C. jejuni PCK to adenosine phosphates. In addition, higher intracellular PEP pools may account for the decreased PCK activity observed in the pyk mutant. The inability of the pycB mutant, which possesses low levels of PCK, to grow on malate as a sole carbon source is consistent with this enzyme functioning predominantly as a gluconeogenic OAA decarboxylase. Bacillus subtilis and E. coli pck mutants are, similarly, unable to grow on CAC intermediates, although they grow normally on glucose (Diesterhaft & Freese, 1973 ; Goldie & Sanwal, 1980) . The carboxylation reaction was not saturable at bicarbonate concentrations up to 140 mM, precluding a role for PCK in PEP carboxylation, as the organism is unlikely to encounter such high bicarbonate concentrations under physiological conditions. A role in NADPH generation for biosynthesis is a possible function for MEZ, similar to the MEZs of Corynebacterium glutamicum and Aspergillus nidulans (Gourdon et al., 2000 ; Wynn & Ratledge, 1997) . However, the very low affinity of the MEZ of Campylobacter jejuni for malate and the comparable phenotype of the mez mutant to that of the wild-type is suggestive of a minor anaplerotic role for this enzyme in C. jejuni.
